POSS-Based Biodegradable Polymers for Stent Applications: Electroprocessing, Characterization and Controlled Drug Release

POSS-Based Biodegradable Polymers for Stent Applications: Electroprocessing, Characterization and Controlled Drug Release

Bibliographic Details
Main Author:	Guo, Qiongyu
Language:	English
Published:	Case Western Reserve University School of Graduate Studies / OhioLINK 2010
Subjects:	Biomedical Research Polymers POSS biodegradable polymer drug delivery drug-eluting stents polymeric stent drug release modeling paclitaxel electrostatic processing electrospraying electrospinning coating roughness miscibility specific interactions shape memory
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=case1259706279

Similar Items

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
by: Walid Maamoun
Published: (2013-09-01)

Influence of Elongation of Paclitaxel-Eluting Electrospun-Produced Stent Coating on Paclitaxel Release and Transport Through the Arterial Wall after Stenting
by: Zhanna K. Nazarkina, et al.
Published: (2021-04-01)

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
by: Alberto Chisari, et al.
Published: (2016-09-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
by: Xiao-Fang Tang, et al.
Published: (2018-08-01)

Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience.
by: Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France), et al.
Published: (2021-01-01)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
by: Leos Pleva, et al.
Published: (2017-06-01)

Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model
by: Takeshi Ijichi, et al.
Published: (2021-06-01)

Clinical analysis of permanent, biodegradable and polymer-free drug eluting stent in treatment of unprotected left main coronary artery disease
by: ZHOU Denglu, et al.
Published: (2019-03-01)

Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
by: Ajmera P, et al.
Published: (2019-10-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

Vascular Stents Coated with Electrospun Drug-Eluting Material: Functioning in Rabbit Iliac Artery
by: Konstantin A. Kuznetsov, et al.
Published: (2020-08-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Clinical performance of biodegradable polymer coated Sirolimus-eluting stent in multivessel disease: Results from MULTIDES study
by: Anurag Polavarapu, et al.
Published: (2016-01-01)

Coronary artery aneurysms following drug eluting stents implantation: A retrospective analysis from series of cases at tertiary care cardiac centre over three years
by: Sudarshan Kumar Vijay, et al.
Published: (2019-01-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
by: Paweł Gąsior, et al.
Published: (2018-11-01)

Coronary Stents: History, Design, and Construction
by: Torrey Schmidt, et al.
Published: (2018-05-01)

Long-term Clinical Results for Randomised Comparison of Paclitaxel-eluting versus Bare-metal Stents in Unprotected Left Main Coronary Artery Disease
by: Narbute Inga, et al.
Published: (2009-01-01)

Paclitaxel Drug-eluting Tracheal Stent Could Reduce Granulation Tissue Formation in a Canine Model
by: Ting Wang, et al.
Published: (2016-01-01)

Sirolimus-Eluting Electrospun-Produced Matrices as Coatings for Vascular Stents: Dependence of Drug Release on Matrix Structure and Composition of the External Environment
by: Zhanna K. Nazarkina, et al.
Published: (2020-06-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Rhombic-Shaped Channel Stent with Enhanced Drug Capacity and Fatigue Life
by: Hao-Ming Hsiao, et al.
Published: (2017-12-01)

Influence of Polymer Composition on the Controlled Release of Docetaxel: A Comparison of Non-Degradable Polymer Films for Oesophageal Drug-Eluting Stents
by: Paris Fouladian, et al.
Published: (2020-05-01)

Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort
by: E. Xhepa, et al.
Published: (2014-05-01)

Stent thrombosis: Prevention and management
by: Rajendra Kumar Jain, et al.
Published: (2014-01-01)

Biodegradable Stent with mTOR Inhibitor-Eluting Reduces Progression of Ureteral Stricture
by: Dong-Ru Ho, et al.
Published: (2021-05-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: a meta-analysis of randomized control trials
by: Kang Gao, et al.
Published: (2017-07-01)

Late and Very Late Stent Thrombosis in the Era of Second Generation Drug Eluding Stents
by: Jaya Mallidi, et al.
Published: (2016-08-01)

Use of a fluoropolymer-based paclitaxel-eluting stent for arteriovenous graft outflow vein stenosis in hemodialysis patients
by: Yuki Matsuoka, MD, MBA, et al.
Published: (2021-06-01)

Drug-eluting metallic stents in urology
by: Panagiotis S Kallidonis, et al.
Published: (2014-01-01)

First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study
by: Raban Jeger, et al.
Published: (2016-11-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
by: Lee CH, et al.
Published: (2018-10-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
by: Surender Deora, et al.
Published: (2014-07-01)

Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View
by: Atsushi Sakamoto, et al.
Published: (2018-09-01)

Gene Delivery from Stents for Prevention of In Stent Restenosis
by: Ilia Fishbein, et al.
Published: (2016-12-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
by: Kong-Yong Cui, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_vjc9tgrarfgprdlcln06edqmmm